T. W. Slone

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

C. J. Peters, John A. Reynolds, T. W. Slone et al. · Antiviral Research · 1986 · 144 citations

Life Sciences, Immunology, Infectious Diseases +17

Experimental Rift Valley fever in rhesus macaques

C. J. Peters, D. Jones, R.W. Trotter et al. · Archives of Virology · 1988 · 101 citations

Veterinary Medicine, Biology, Infectious Diseases +14

Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in Sprague–Dawley rats

Jessica M. Caverly Rae, Lisa Craig, T. W. Slone et al. · Toxicology Reports · 2015 · 99 citations · Full text

Pharmacy, Pharmacology, Toxicology +12

Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats

G.W. Anderson, T. W. Slone, C. J. Peters · Microbial Pathogenesis · 1987 · 88 citations

Veterinary Medicine, Infectious Diseases, Microbiology +13

Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman.

John H. McDonough, Tyler Clark, T. W. Slone et al. · PubMed · 1998 · 84 citations

Medicine, Neurobiology, Neuroscience +15